David C. Hooper

33.1k total citations · 11 hit papers
274 papers, 24.2k citations indexed

About

David C. Hooper is a scholar working on Molecular Medicine, Molecular Biology and Infectious Diseases. According to data from OpenAlex, David C. Hooper has authored 274 papers receiving a total of 24.2k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Molecular Medicine, 110 papers in Molecular Biology and 98 papers in Infectious Diseases. Recurrent topics in David C. Hooper's work include Antibiotic Resistance in Bacteria (138 papers), Antibiotics Pharmacokinetics and Efficacy (83 papers) and Antimicrobial Resistance in Staphylococcus (78 papers). David C. Hooper is often cited by papers focused on Antibiotic Resistance in Bacteria (138 papers), Antibiotics Pharmacokinetics and Efficacy (83 papers) and Antimicrobial Resistance in Staphylococcus (78 papers). David C. Hooper collaborates with scholars based in United States, China and South Korea. David C. Hooper's co-authors include George A. Jacoby, J S Wolfson, Ari Robicsek, Jacob Strahilevitz, Anton Y. Peleg, Chi Hye Park, Q. C. Truong-Bolduc, E Y Ng, Bénédicte Fournier and Morton N. Swartz and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

David C. Hooper

270 papers receiving 23.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hospital-Acquired Infections Due to Gram-Negative Bacteria

2010 1.1k citations David C. Hooper et al. profile →
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase

2005 750 citations Ari Robicsek, Jacob Strahilevitz et al. profile →
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat

2009 729 citations Jacob Strahilevitz, George A. Jacoby et al. profile →
Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy

1991 706 citations David C. Hooper et al. profile →
The worldwide emergence of plasmid-mediated quinolone resistance

2006 699 citations Ari Robicsek, George A. Jacoby et al. profile →
Prevalence in the United States of aac(6 ′ ) - Ib - cr Encoding a Ciprofloxacin-Modifying Enzyme

2006 631 citations Chi Hye Park, Ari Robicsek et al. Antimicrobial Agents and Chemotherapy profile →
The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

1985 603 citations David C. Hooper et al. Antimicrobial Agents and Chemotherapy profile →
Fluoroquinolone antimicrobial agents

1989 535 citations David C. Hooper et al. profile →
Mechanisms of drug resistance: quinolone resistance

2015 471 citations David C. Hooper, George A. Jacoby profile →
Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents

2018 377 citations Michael Klompas, David C. Hooper et al. Clinical Infectious Diseases profile →
Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance

2016 359 citations David C. Hooper, George A. Jacoby profile →

Peers

Countries citing papers authored by David C. Hooper

Since Specialization

Citations

This map shows the geographic impact of David C. Hooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Hooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Hooper more than expected).

Fields of papers citing papers by David C. Hooper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Hooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Hooper. The network helps show where David C. Hooper may publish in the future.

Co-authorship network of co-authors of David C. Hooper

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Hooper. A scholar is included among the top collaborators of David C. Hooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Hooper. David C. Hooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Environmental cues in different host niches shape the survival fitness of Staphylococcus aureus 2025 ·Nature Communications ·JuOae Chang, (unknown), (unknown), Jihyeon Kim, Ji Hoon Kim, (unknown), David C. Hooper, Suzanne Walker, Wonsik Lee	0
2	Second Time's the Charm? Assessing the Sensitivity and Yield of Inpatient Diagnostic Algorithms for Pulmonary Tuberculosis in a Low-Prevalence Setting 2024 ·Open Forum Infectious Diseases ·Caitlin M. Dugdale, Kimon C. Zachary, Dustin McEvoy, John A. Branda, Amy N. Courtney, Rebecca L. Craig, (unknown), (unknown), (unknown), (unknown), David C. Hooper, Rocio Hurtado, Emily P. Hyle, (unknown), Jacob E. Lazarus, Molly L Paras, Sarah E. Turbett, Erica S. Shenoy	1
3	Blue Light Compromises Bacterial β‐Lactamases Activity to Overcome β‐Lactam Resistance 2024 ·Lasers in Surgery and Medicine ·Carolina dos Anjos, Yin Wang, Q. C. Truong-Bolduc, (unknown), Matt Liu, David C. Hooper, R. Rox Anderson, Tianhong Dai, Leon G. Leanse	5
4	Use of expert consensus to develop a shared list of procedures with potential for aerosol generation during the coronavirus disease 2019 (COVID-19) pandemic 2023 ·SHILAP Revista de lepidopterología ·(unknown), Preeti Mehrotra, Lou Ann Bruno‐Murtha, Robert C. Colgrove, Shira Doron, Robert Duncan, Richard T. Ellison, Sarah Haessler, David C. Hooper, Michael Klompas, Cassandra Pierre, Thomas J. Sandora, Erica S. Shenoy, Sharon B. Wright	1
5	Metallo-β-Lactamases: Structure, Function, Epidemiology, Treatment Options, and the Development Pipeline 2020 ·Antimicrobial Agents and Chemotherapy ·Sara E. Boyd, David M. Livermore, David C. Hooper, William Hope	199
6	Safety of Delafloxacin: Focus on Adverse Events of Special Interest 2018 ·Open Forum Infectious Diseases ·Thomas P. Lodise, Ralph Corey, David C. Hooper, Sue Cammarata	27
7	A Generalizable, Data-Driven Approach to Predict Daily Risk ofClostridium difficileInfection at Two Large Academic Health Centers 2018 ·Infection Control and Hospital Epidemiology ·(unknown), Maggie Makar, (unknown), Robert J. McCaffrey, Krishna Rao, Erin Ryan, Laraine Washer, (unknown), Vincent B. Young, John Guttag, David C. Hooper, Erica S. Shenoy, Jenna Wiens	89
8	Antibiotic That Inhibits the ATPase Activity of an ATP-Binding Cassette Transporter by Binding to a Remote Extracellular Site 2017 ·Journal of the American Chemical Society ·Leigh M. Matano, (unknown), (unknown), Sara E. Martin, Wonsik Lee, Tristan W. Owens, (unknown), Hidemasa Nakaminami, David C. Hooper, Timothy C. Meredith, Suzanne Walker	19
9	Mutations That Enhance the Ciprofloxacin Resistance of Escherichia coli with qnrA1 2015 ·Antimicrobial Agents and Chemotherapy ·Laura Vinué, (unknown), David C. Hooper, George A. Jacoby	40
10	Comparative Evaluation of the Tolerability of Cefazolin and Nafcillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections in the Outpatient Setting 2014 ·Clinical Infectious Diseases ·Ilan Youngster, Erica S. Shenoy, David C. Hooper, Sacha B. Nelson	68
11	Discontinuation of Contact Precautions for Methicillin-Resistant Staphylococcus aureus: A Randomized Controlled Trial Comparing Passive and Active Screening With Culture and Polymerase Chain Reaction 2013 ·Clinical Infectious Diseases ·Erica S. Shenoy, Jason Kim, Eric Rosenberg, Jennifer Cotter, Hang Lee, Rochelle P. Walensky, David C. Hooper	36
12	Phosphorylation of MgrA and Its Effect on Expression of the NorA and NorB Efflux Pumps of Staphylococcus aureus 2010 ·Journal of Bacteriology ·Q. C. Truong-Bolduc, David C. Hooper	68
13	Ertapenem-Resistant Enterobacteriaceae Risk Factors for Acquisition and Outcomes 2010 ·Infection Control and Hospital Epidemiology ·Emily P. Hyle, M J Ferraro, (unknown), (unknown), David C. Hooper	38
14	New Plasmid-Mediated Quinolone Resistance Gene, qnrC , Found in a Clinical Isolate of Proteus mirabilis 2009 ·Antimicrobial Agents and Chemotherapy ·Minghua Wang, Qinglan Guo, Xiaogang Xu, Xiaoying Wang, Xinyu Ye, Shi Wu, David C. Hooper, Minggui Wang	270
15	NorC, a New Efflux Pump Regulated by MgrA of Staphylococcus aureus 2006 ·Antimicrobial Agents and Chemotherapy ·Q. C. Truong-Bolduc, Jacob Strahilevitz, David C. Hooper	107
16	qnr Prevalence in Ceftazidime-Resistant Enterobacteriaceae Isolates from the United States 2006 ·Antimicrobial Agents and Chemotherapy ·Ari Robicsek, Jacob Strahilevitz, D.F. Sahm, George A. Jacoby, David C. Hooper	477
17	Prevalence in the United States of aac(6 ′ ) - Ib - cr Encoding a Ciprofloxacin-Modifying Enzyme breakdown → 2006 ·Antimicrobial Agents and Chemotherapy ·Chi Hye Park, Ari Robicsek, George A. Jacoby, Daniel F. Sahm, David C. Hooper	631
18	Characterization of NorR Protein, a Multifunctional Regulator of norA Expression in Staphylococcus aureus 2003 ·Journal of Bacteriology ·Q. C. Truong-Bolduc, Xiamei Zhang, David C. Hooper	109
19	NorA Functions as a Multidrug Efflux Protein in both Cytoplasmic Membrane Vesicles and Reconstituted Proteoliposomes 2002 ·Journal of Bacteriology ·Jianlin Yu, (unknown), David C. Hooper	79
20	A Mutation in the 5′ Untranslated Region Increases Stability of norA mRNA, Encoding a Multidrug Resistance Transporter of Staphylococcus aureus 2001 ·Journal of Bacteriology ·Bénédicte Fournier, Q. C. Truong-Bolduc, Xiamei Zhang, David C. Hooper	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact